Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review-Reference-Cited by-同舟云学术

Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review

Published:2022-03-02 Issue:6 Volume:108 Page:469-485
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:European J of Haematology

Author:

Vu Martin¹²^ORCID,Degeling Koen¹²^ORCID,Thompson Ella R.³⁴^ORCID,Blombery Piers³⁴⁵^ORCID,Westerman David³⁴⁵,IJzerman Maarten J.¹²⁶⁷^ORCID

Affiliation:

1. Cancer Health Services Research, Centre for Cancer Research, Faculty of Medicine, Dentistry and Health Sciences The University of Melbourne Melbourne Australia

2. Cancer Health Services Research, Centre for Health Policy, Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences The University of Melbourne Melbourne Australia

3. Pathology Department Peter MacCallum Cancer Centre Melbourne Australia

4. Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne Australia

5. Clinical Haematology Peter MacCallum Cancer Centre/Royal Melbourne Hospital Melbourne Australia

6. Department of Cancer Research Peter MacCallum Cancer Centre Melbourne Australia

7. Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre University of Twente Enschede The Netherlands

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13755

Reference78 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century

3. Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting

4. American Cancer Society.Cancer facts & figures 2021.2021;https://www.cancer.org/research/cancer‐facts‐statistics/all‐cancer‐facts‐figures/cancer‐facts‐figures‐2021.htmlAccessed 22 June 2021.

5. Economic burden of malignant blood disorders across Europe: a population-based cost analysis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of the mechanism of USP28-mediated IFITM3 elevation in BCR-ABL-dependent imatinib resistance in CML;Biomedicine & Pharmacotherapy;2024-04

2. Integrating genomics into Canadian oncology nursing policy: Insights from a comparative policy analysis;Journal of Advanced Nursing;2024-03-21

3. Genomics-informed nursing strategies and health equity: A scoping review protocol;PLOS ONE;2023-12-15